JIE LI: Open Payments
NPI 1215713276 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $226 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $186 |
| Gilead Sciences, Inc. | 1 | $125 |
| Madrigal Pharmaceuticals | 4 | $96 |
| PFIZER INC. | 3 | $60 |
| Novo Nordisk Inc | 2 | $36 |
| LEO Pharma Inc. | 1 | $26 |
| Organon LLC | 1 | $22 |
| BeiGene USA, Inc. | 1 | $20 |
Products named: XIFAXAN, Epclusa, REZDIFFRA, XELJANZ, Wegovy, ADBRY, VTAMA, BRUKINSA.
Industry payments across NY — which companies pay providers there.
